<SEC-DOCUMENT>0001193125-15-031519-index.html : 20150203
<SEC-HEADER>0001193125-15-031519.hdr.sgml : 20150203
<ACCEPTANCE-DATETIME>20150203161635
ACCESSION NUMBER:		0001193125-15-031519
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20150130
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150203
DATE AS OF CHANGE:		20150203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		15571318

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d864170d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: d864170d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d864170dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 2 - file: d864170dex101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d864170dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d864170dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>d864170dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 4 - file: d864170dex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g864170g53u96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g864170g53u96.jpg

</DOCUMENT>
</SEC-DOCUMENT>